Sarcomas Completed Phase 2 Trials for Vincristine (DB00541)

Also known as: Sarcoma / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Soft tissue sarcoma

IndicationStatusPhase
DBCOND0041813 (Sarcomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00061893Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of TumorsTreatment
NCT00002466Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerTreatment
NCT00003667Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's SarcomaTreatment
NCT00002643Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorTreatment
NCT00002804Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue SarcomaTreatment
NCT00003955Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or SarcomaTreatment
NCT00025441Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal TumorsTreatment
NCT00043979Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasTreatment
NCT00267046Evaluate PKs and Efficacy Assessment of Palifermin in Patients With SarcomaPrevention